Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Capital Expenditures (2017 - 2026)

Updated

Crinetics Pharmaceuticals (CRNX) posted Capital Expenditures of $521,000 for Q2 2026, down 83.7% from $3.2 million a year earlier and down 36.5% from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Capital Expenditures (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Crinetics Pharmaceuticals was $2.66 million, down 55.6% year-over-year; for FY2025, it came in at $5.76 million, up 49.9% from FY2024.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of 98.7% (FY2020 to FY2025).
  • In prior years, Crinetics Pharmaceuticals' Capital Expenditures was $3.84 million in FY2024 (-18.0%), $4.69 million in FY2023 (+183.1%), $1.66 million in FY2022 (+279.8%) and $436,000 in FY2021 (+134.4%).
  • Quarterly Capital Expenditures has run from a low of $16,000 in Q1 2023 to a high of $3.5 million in Q3 2023 over five years.
  • On a year-over-year basis, Capital Expenditures has declined in each of the last three quarters, with growth averaging 5.5% over the last eight quarters.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2023, with growth of 413.2%; the weakest was Q3 2024, with a decline of 84.9%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $820,000 (Q1 2026), $458,000 (Q4 2025) and $863,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn 521,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 521,000.00
Mar 31, 2026 820,000.00
Dec 31, 2025 458,000.00
Sep 30, 2025 863,000.00
Jun 30, 2025 3.20 Mn
Mar 31, 2025 1.24 Mn
Dec 31, 2024 1.03 Mn
Sep 30, 2024 528,000.00
Jun 30, 2024 955,000.00
Mar 31, 2024 1.33 Mn
Dec 31, 2023 935,000.00
Sep 30, 2023 3.50 Mn
Jun 30, 2023 237,000.00
Mar 31, 2023 16,000.00
Dec 31, 2022 274,000.00
Sep 30, 2022 682,000.00
Jun 30, 2022 613,000.00
Mar 31, 2022 87,000.00
Dec 31, 2021 18,000.00
Sep 30, 2021 140,000.00
API Access

Crinetics Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CRNX&period=max&api_key=YOUR_API_KEY